$RKLBBearishMed

RKLB, LUNR, SPCE, and Planet Labs May Crash Ahead of SpaceX IPO

Space stocks have surged this year on expectations for a SpaceX IPO that could value the company above $1.7 trillion, with Polymarket traders projecting over $2 trillion. The Procure Space ETF (UFO) is up 146% in 12 months; Rocket Lab (RKLB) is up 382% to a $83B market cap. The article warns of a “buy the rumor, sell the news” pullback and high valuations (Planet Labs forward P/S 51; RKLB 91).

7/10
4/10
Med
Bearish
Ahead of the anticipated SpaceX IPO / around the “sell the news” window
Bearish risk framing on crowded space-name positioning (overbought/overvalued)

High-beta read-through to SpaceX IPO expectations; article flags overvaluation/overbought risk that could trigger a near-term pullback.

Rocket Lab is cited as a close SpaceX competitor whose shares could drop on “buy the rumor, sell the news” and extreme valuation multiples.

Potential downside volatility ahead of/around SpaceX IPO as crowded positioning unwinds.

Background

The article argues that space stocks have rallied in anticipation of a large SpaceX IPO and that the group may be vulnerable to a post-event reversal.

Why it matters

It frames a near-term downside setup for RKLB, LUNR, SPCE, and PL based on “buy the rumor, sell the news,” stretched forward P/S multiples, and overbought/overvalued technical conditions.

Market relevance

Space-name rallies are attributed to SpaceX IPO expectations; the article’s core trade idea is a potential selloff from crowded positioning and valuation/technical stretch.

Market effects

Reinforces a crowded, sentiment-driven trade in space equities where IPO expectations can reverse via valuation compression and technical de-risking.

Primarily US-listed space complex sentiment; could spill into broader growth/space-adjacent risk appetite.

Space IPO narrative is global for satellite/launch/tourism themes; could affect international space-related equity sentiment even if catalysts are US-based.

Alternative perspectives

If SpaceX IPO details exceed expectations or trigger sustained capital inflows into the space supply chain, the “sell the news” thesis may be delayed or muted.

The article cites valuation/technical risk but provides no new catalyst dates, fundamentals, or IPO-specific details; actual timing and IPO messaging could change the path of these stocks.

Key entities

  • SpaceX

    Anticipated IPO is described as valuing Elon Musk’s company above $2T, driving read-across into space equities.

  • Procure Space ETF (UFO)

    Mentioned as having surged, indicating broad space-equity inflows and crowded positioning.

  • Tema Space Innovators (NASA) ETF

    Mentioned as growing rapidly, reinforcing momentum/inflow backdrop for the space complex.

Related articles

$LUNRMedAI 8/10

Intuitive Machines (LUNR) Stock Is Sinking. The SpaceX IPO Is Only Partly to Blame.

Intuitive Machines shares fell on Wednesday, with the article saying the SpaceX IPO is only partly responsible. It notes a share-issuance program run by a consortium of 10 financial institutions (including Barclays, Cantor Fitzgerald, and Deutsche Bank) that can collect up to 3% commissions and allows continuous issuance at market prices, creating dilution risk. Analysts maintain a “Moderate Buy” consensus and a mean ~$41 price target (~20% upside).

$PLMedAI 9/10

Planet Labs Posts Record Quarterly Revenue, Stock Slides Anyway - Planet Labs (NYSE:PL)

Planet Labs reported Q1 adjusted loss of 3 cents per share, better than the 4-cent consensus, and revenue of $94.15 million, above the $89.85 million estimate and up 42% year over year. Remaining performance obligations rose to $816 million and backlog to $906+ million. The company raised FY2027 revenue guidance to $425–$441 million. Shares were down about 7.6% to $40.22.

$RKLBLow

Should You Buy RocketLab Stock Instead of SpaceX at IPO?

The article discusses rising investor interest in space-related stocks, highlighting Rocket Lab (RKLB) shares up 4.61% as of June 2, 2026 afternoon prices. It frames the question of whether Rocket Lab stock should be considered instead of SpaceX around its IPO, but provides no additional financial figures or company-specific details.

$RKLBMed

Space nerds, rejoice! SpaceX’s IPO lifts dreams of the cosmos.

SpaceX’s upcoming IPO has drawn major attention from space enthusiasts and investors. The company set an IPO price of $135 per share, valuing it at about $1.77 trillion, according to the report. RocketLab and Intuitive Machines shares have risen as the deal nears, and analysts said a successful IPO could boost broader space-industry investment.

$PLMedAI 9/10

Planet Labs Q1 Loss Widens, But Revenue Jumps 42%

Planet Labs PBC reported a wider Q1 net loss of $138.9 million ($0.40/share) versus a $12.6 million loss ($0.04/share) a year earlier, largely due to a one-time non-cash $106.5 million charge from revaluing warrant liabilities. Revenue rose 42% to $94.2 million. Adjusted loss was $8.8 million ($0.03/share). The company forecast Q2 revenue of $102–$107 million and FY2027 revenue of $425–$441 million.